Literature DB >> 3494512

Effect of exogenous interleukins on in vitro responses of T lymphocytes from patients with Hodgkin disease.

R Mukhopadhyaya, S H Advani, S G Gangal.   

Abstract

PHA-induced peripheral blood lymphocyte (PBL) proliferation and T-cell colony formation in soft agar was studied in the presence of interleukin-2 (IL-2) containing medium in untreated Hodgkin disease (HD) patients and normal controls. The proliferative response of HD PBL was potentiated in presence of IL-2-containing medium in 11 of 20 cases studied, and there was marginal increase or inhibition of PHA response in 16 normal lymphocyte samples. Lymphocytes from patients in advanced stages of the disease, and those who were initially hyporesponsive responded better to suboptimal doses of PHA in the presence of exogenous IL-2. There was no improvement in the colony forming capacity of T lymphocytes from HD PBL even in the presence of IL-2-containing medium, whereas normal T-cell colony formation was augmented significantly both in number and in size of colonies.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3494512

Source DB:  PubMed          Journal:  Cancer Detect Prev        ISSN: 0361-090X


  4 in total

1.  Impairment in proliferation, lymphokine production and frequency distribution of mitogen-responsive and interleukin-2-producing cells in Hodgkin's disease.

Authors:  R N Damle; S H Advani; S G Gangal
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

2.  Affinity of IL-2 receptors and proliferation of mitogen activated lymphocytes in Hodgkin's disease.

Authors:  R N Damle; R J Tatake; S H Advani; S G Gangal
Journal:  Br J Cancer       Date:  1990-03       Impact factor: 7.640

3.  Natural killer and lymphokine activated killer cell functions in Hodgkin's disease.

Authors:  N Rajaram; R J Tatake; S H Advani; S G Gangal
Journal:  Br J Cancer       Date:  1990-08       Impact factor: 7.640

4.  Functional evaluation of T-lymphocytes from peripheral blood and spleens in Hodgkin's disease.

Authors:  R Mukhopadhyaya; S H Advani; S G Gangal
Journal:  Br J Cancer       Date:  1987-12       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.